Additionally, we analyzed the single-cell sequencing data of primary sclerosing cholangitis (PSC) patients (shown in Supplementary Figure S1A) and found significant changes in FGF21 expression, indicating the potential of FGF21 as a therapeutic target in the treatment of cholestasis. Here, FGF21 is linked to cholestasis.